Trials / Completed
CompletedNCT04375865
Evaluating the Pharmacokinetic Interactions and Safety Between AD-2111 and AD-2112
A Phase I Clinical Trial to Evaluate the Pharmacokinetic Interactions and Safety Between AD-2111 and AD-2112 in Healthy Adult Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Addpharma Inc. · Industry
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Accepted
Summary
A phase I clinical trial to evaluate the pharmacokinetic interactions and safety between AD-2111 and AD-2112
Detailed description
Purpose: pharmacokinetic interactions and safety of AD-2111 and AD-2112 in healthy adult volunteers Condition or disease : Pain Intervention/treatment Drug : AD-2111(Celecoxib 200mg), AD-2112(Tramadol 150mg) Phase : Phase 1
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | AD-2111 | celecoxib 200mg |
| DRUG | AD-2112 | Tramadol 150mg |
Timeline
- Start date
- 2020-05-30
- Primary completion
- 2020-07-16
- Completion
- 2020-07-16
- First posted
- 2020-05-06
- Last updated
- 2020-11-06
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT04375865. Inclusion in this directory is not an endorsement.